{"id":3835,"date":"2024-10-28T04:00:04","date_gmt":"2024-10-28T08:00:04","guid":{"rendered":"https:\/\/happylungsproject.org\/?p=3835"},"modified":"2026-03-02T10:53:05","modified_gmt":"2026-03-02T15:53:05","slug":"ethical-considerations-in-ret-lung-cancer-clinical-trials","status":"publish","type":"post","link":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/","title":{"rendered":"Ethical Considerations in RET Lung Cancer Clinical Trials"},"content":{"rendered":"[vc_row type=&#8221;in_container&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;padding-3-percent&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color=&#8221;#f68d28&#8243; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; font_color=&#8221;#ffffff&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;10px&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221; column_padding_type=&#8221;default&#8221; gradient_type=&#8221;default&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<p data-pm-slice=\"1 1 []\"><span data-color=\"var(--orange-10)\">For those with RET lung cancer, clinical trials represent hope. However, they also raise ethical considerations. Let&#8217;s explore informed consent, patient rights, safety measures, and regulatory oversight to help you understand what to expect and ensure your participation in oncology clinical trials is as safe as possible.<\/span><\/p>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\"><strong>Understanding RET Lung Cancer Clinical Trials<\/strong><\/h2>\n<p>Participating in oncology clinical trials can be a vital step for many lung cancer patients, offering access to potentially life-saving treatments.<\/p>\n<p>RET lung cancer is a subset of non-small cell lung cancer (NSCLC) characterized by alterations in the RET gene. The most common RET alterations in lung cancer are the abnormal re-arrangement or fusions of the RET gene with other fusion gene partners. These fusions lead to constitutive activation of the RET kinase, which produces uncontrolled cell growth and cancer.<\/p>\n<p>Clinical trials for RET-targeted therapies are crucial for advancing medical research and developing effective treatments for RET lung cancer. Clinical research or clinical trials are exhaustively monitorized to ensure safety and quality of life of the cancer patients. Guaranteeing safety, protection of rights, and confidentiality of patients participating in clinical trials are key factors of good clinical practice, and ethical concerns must be considered to ensure patient safety.<\/p>\n<h2 data-pm-slice=\"1 1 []\"><strong>Informed Consent of Clinical Trials<\/strong><\/h2>\n<p>Informed consent is the process by which a health care provider communicates to a patient about:<\/p>\n<ul>\n<li>Nature of the procedure<\/li>\n<li>Risks, benefits, and alternatives to the medical procedure or treatment, genetic testing, or clinical research study<\/li>\n<li>Right to withdraw<\/li>\n<\/ul>\n<p>Informed consent is essential in clinical trials practice and is both an ethical and legal obligation of medical practitioners in the U.S., allowing patients to make an informed, voluntary decision about their care.<\/p>\n<p>Informed consent must be clear and easy to understand; the consent form must be given in writing and may be discussed with the doctors and nurses or the research team. A patient always has the right to withdraw from a clinical trial at any time.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][toggles style=&#8221;minimal_shadow&#8221; accordion=&#8221;true&#8221; accordion_starting_functionality=&#8221;closed&#8221; border_radius=&#8221;none&#8221;][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Patient Rights&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">Your Rights as a Patient<\/h2>\n<p>You have the right to receive all necessary information about the clinical trial, including:<\/p>\n<ul>\n<li>Purpose and duration<\/li>\n<li>Procedures and risks<\/li>\n<li>Alternatives<\/li>\n<li>Right to withdraw<\/li>\n<\/ul>\n<h3><strong>Purpose and Duration <\/strong><\/h3>\n<p>Make sure you understand why the trial is being conducted and how long it will last.<\/p>\n<h3><strong>Procedures and Risks<\/strong><\/h3>\n<p>A valid informed consent must contain all details about the treatment you are undergoing as part of the clinical trial, including details about known risks or side effects and how likely the treatment is to succeed.<\/p>\n<h3><strong>Alternatives to the Clinical Trial<\/strong><\/h3>\n<p>You should be given information about other available treatments that you, as the patient, might want to consider.<\/p>\n<h3><strong>Right to Withdraw from the Clinical Trial<\/strong><\/h3>\n<p>You have the right to leave the trial at any time, even if it is not completed, without any negative consequences on your standard care.<\/p>\n<p>Before you join a clinical trial, you should discuss with your healthcare team the clinical trial&#8217;s purpose, risks, benefits, alternatives, and right to withdraw. It&#8217;s critical to fully understand what you&#8217;re agreeing to, and to feel comfortable asking questions.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Safety Measures&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\"><strong>Patient Rights and Safety Measures in Clinical Trials<\/strong><\/h2>\n<p>Patient rights in clinical research and clinical cancer trials ensure you are treated ethically and with respect. Here are some key points to consider related to cancer trial ethical issues:<\/p>\n<h3><strong>Confidentiality<\/strong><\/h3>\n<p>Personal and medical information should be kept confidential when a patient participates in a clinical trial.<\/p>\n<h3><strong>Safety Monitoring<\/strong><\/h3>\n<p>Clinical trials are closely monitored for safety, with specific protocols in place to ensure any adverse events (AEs) are promptly addressed.<\/p>\n<p>Adverse events are any undesirable experiences associated with a treatment that is being tested in a patient. In clinical trials, AEs are graded based on severity, with grade 1 being asymptomatic or mild, grade 2 being moderate, grade 3 being severe, and grade 4 being life-threatening.<\/p>\n<h3><strong>Access to Care<\/strong><\/h3>\n<p>Even while in a clinical trial, you should continue to receive the best standard of care for your condition.<\/p>\n<h3><strong>Compensation for Injury<\/strong><\/h3>\n<p>In the rare event of injury or harm due to the clinical trial, there should be a clear process for compensation.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Regulatory Oversight&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\"><strong>Regulatory Oversight in Clinical Trials<\/strong><\/h2>\n<p>Regulatory agencies, like the Food and Drug Administration (FDA) in the United States, oversee clinical research cancer trials to ensure they meet ethical standards. Here are some ways regulatory oversight helps protect you:<\/p>\n<h3><strong>Institutional Review Boards<\/strong><\/h3>\n<p>Clinical trials in the U.S. must be approved by an institutional review board (IRB) that is an independent group (doctors, scientist, etc) that has been formally designated to review and monitor lung cancer research involving human subjects.<\/p>\n<p>The purpose of the IRB review is to assure that appropriate steps are taken to protect the rights and welfare of humans participating in randomized trials. The IRB regularly review the study to ensure they are ethical and that risks are minimized.<\/p>\n<h3><strong>Data Safety Monitoring Boards<\/strong><\/h3>\n<p>Data safety monitoring boards (DSMBs) are independent groups that monitor ongoing trials for safety and recommend adjustments if needed. They evaluate whether a trial is being conducted according to the approved protocol as well as any adverse events associated with the treatment, ensuring that participant safety is maintained throughout the clinical trials.<\/p>\n<h3><strong>Adherence to Regulations<\/strong><\/h3>\n<p>Clinical trials must comply with regulations like the Declaration of Helsinki, which sets ethical principles for medical research.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Diversity&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">Importance of Ensuring Diversity<\/h2>\n<p>Clinical trials should include diverse populations to ensure that the treatments that are being tested effectively across various demographic groups (race, ethnicity, gender, age, socioeconomic status, and geographic location). This also ensures that the treatments are safe for all the patients enrolled.<\/p>\n<p>Historically, certain demographic groups have been underrepresented in clinical trials, leading to gaps in understanding how treatments affect these groups. It is important to ensure that all groups benefit from advances in clinical trials research.[\/vc_column_text][\/toggle][toggle color=&#8221;Accent-Color&#8221; heading_tag=&#8221;h3&#8243; heading_tag_functionality=&#8221;default&#8221; title=&#8221;Informed Decision&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\"><strong>Making an Informed Decision<\/strong><\/h2>\n<p>Clinical trial participation can make a significant difference in a patient&#8217;s care. However, it is crucial to weigh a clinical trial&#8217;s risks and benefits and to understand your rights as a patient. Talk to your healthcare team, ask questions, and make sure you are comfortable with the trial&#8217;s goals, procedures, and potential risks before making a decision to participate.<\/p>\n<p>Remember, your safety and well-being are the top priority. With the right information and guidance, you can make an informed choice about participating in a RET lung cancer clinical trial.[\/vc_column_text][\/toggle][\/toggles][vc_row_inner column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_direction_desktop=&#8221;default&#8221; column_element_spacing=&#8221;default&#8221; desktop_text_alignment=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_backdrop_filter=&#8221;none&#8221; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; overflow=&#8221;visible&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]\n<h2 data-pm-slice=\"1 1 []\">References and Resources<\/h2>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li>https:\/\/www.cancer.org\/cancer\/managing-cancer\/making-treatment-decisions\/informed-consent\/what-is-informed-consent.html<\/li>\n<li>https:\/\/www.lungevity.org\/sites\/default\/files\/request-materials\/LUNGevity-clinical-trials-booklet-033115.pdf<\/li>\n<li>https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\/what-are-clinical-trials<\/li>\n<li>https:\/\/www.cancer.gov\/research\/participate\/clinical-trials\/disease\/non-small-cell-lung\/treatment<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n[\/vc_column_text][vc_column_text css=&#8221;&#8221; text_direction=&#8221;default&#8221;]Your donation matters. Please make a gift today to <a href=\"https:\/\/happylungsproject.org\/donate\/\">support lung cancer research<\/a> and save lives.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>RET lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.<\/p>\n","protected":false},"author":15,"featured_media":3839,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,20],"tags":[],"class_list":{"0":"post-3835","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-clinical-trials","8":"category-treatment"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ethical Considerations in RET Lung Cancer Clinical Trials<\/title>\n<meta name=\"description\" content=\"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ethical Considerations in RET Lung Cancer Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"The Happy Lungs Project\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thehappylungsproject\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T08:00:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:53:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Irene Guijarro Munoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Irene Guijarro Munoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\"},\"author\":{\"name\":\"Irene Guijarro Munoz\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\"},\"headline\":\"Ethical Considerations in RET Lung Cancer Clinical Trials\",\"datePublished\":\"2024-10-28T08:00:04+00:00\",\"dateModified\":\"2026-03-02T15:53:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\"},\"wordCount\":1866,\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png\",\"articleSection\":[\"Clinical Trials\",\"Treatment\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\",\"url\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\",\"name\":\"Ethical Considerations in RET Lung Cancer Clinical Trials\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png\",\"datePublished\":\"2024-10-28T08:00:04+00:00\",\"dateModified\":\"2026-03-02T15:53:05+00:00\",\"description\":\"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.\",\"breadcrumb\":{\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png\",\"width\":640,\"height\":640,\"caption\":\"Randomized clinical trials and research ethics for clinical cancer trials\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/happylungsproject.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ethical Considerations in RET Lung Cancer Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/happylungsproject.org\/#website\",\"url\":\"https:\/\/happylungsproject.org\/\",\"name\":\"The Happy Lungs Project\",\"description\":\"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.\",\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/happylungsproject.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/happylungsproject.org\/#organization\",\"name\":\"The Happy Lungs Project\",\"url\":\"https:\/\/happylungsproject.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"width\":1500,\"height\":1575,\"caption\":\"The Happy Lungs Project\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/thehappylungsproject\",\"https:\/\/www.instagram.com\/thehappylungsproject\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\",\"name\":\"Irene Guijarro Munoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"caption\":\"Irene Guijarro Munoz\"},\"description\":\"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.\",\"sameAs\":[\"https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ethical Considerations in RET Lung Cancer Clinical Trials","description":"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Ethical Considerations in RET Lung Cancer Clinical Trials","og_description":"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.","og_url":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/","og_site_name":"The Happy Lungs Project","article_publisher":"https:\/\/www.facebook.com\/thehappylungsproject","article_published_time":"2024-10-28T08:00:04+00:00","article_modified_time":"2026-03-02T15:53:05+00:00","og_image":[{"width":640,"height":640,"url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png","type":"image\/png"}],"author":"Irene Guijarro Munoz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Irene Guijarro Munoz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/"},"author":{"name":"Irene Guijarro Munoz","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b"},"headline":"Ethical Considerations in RET Lung Cancer Clinical Trials","datePublished":"2024-10-28T08:00:04+00:00","dateModified":"2026-03-02T15:53:05+00:00","mainEntityOfPage":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/"},"wordCount":1866,"publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"image":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png","articleSection":["Clinical Trials","Treatment"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/","url":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/","name":"Ethical Considerations in RET Lung Cancer Clinical Trials","isPartOf":{"@id":"https:\/\/happylungsproject.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png","datePublished":"2024-10-28T08:00:04+00:00","dateModified":"2026-03-02T15:53:05+00:00","description":"Lung cancer clinical trials represent hope. However, they also raise ethical considerations. Let\u2019s explore informed consent, patient rights.","breadcrumb":{"@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#primaryimage","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/10\/randomized-trial-2797448_640.png","width":640,"height":640,"caption":"Randomized clinical trials and research ethics for clinical cancer trials"},{"@type":"BreadcrumbList","@id":"https:\/\/happylungsproject.org\/ethical-considerations-in-ret-lung-cancer-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/happylungsproject.org\/"},{"@type":"ListItem","position":2,"name":"Ethical Considerations in RET Lung Cancer Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/happylungsproject.org\/#website","url":"https:\/\/happylungsproject.org\/","name":"The Happy Lungs Project","description":"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.","publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/happylungsproject.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/happylungsproject.org\/#organization","name":"The Happy Lungs Project","url":"https:\/\/happylungsproject.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","width":1500,"height":1575,"caption":"The Happy Lungs Project"},"image":{"@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thehappylungsproject","https:\/\/www.instagram.com\/thehappylungsproject\/"]},{"@type":"Person","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b","name":"Irene Guijarro Munoz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","caption":"Irene Guijarro Munoz"},"description":"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.","sameAs":["https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/comments?post=3835"}],"version-history":[{"count":2,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3835\/revisions"}],"predecessor-version":[{"id":3840,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/3835\/revisions\/3840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media\/3839"}],"wp:attachment":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media?parent=3835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/categories?post=3835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/tags?post=3835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}